Results vary depending on the cause and extent of hair loss, but many users report noticeable improvements in hair density and thickness within 3-6 months of consistent use
GLP-1R agonists such as semaglutide, tirzepatide, and mazdutide not only promote insulin secretion, suppress appetite, and delay gastric emptying, thereby effectively reducing body weight, but also help improve lipid profiles and reduce the risk of cardiovascular diseases
STUDY GOALS This study aims to evaluate whether retatrutide can reduce the incidence of serious cardiovascular complications or slow the progression of kidney disease in adults with a BMI of 27 kg/m or higher, and diagnosed with established atherosclerotic cardiovascular disease and/or chronic kidney disease, over a period of approximately 5 years
Qi L, Chen X, Wang J, et al